Clinical Trials Logo
  1. Home
  2. Scars
  3. NCT00969475
  4. Details
NCT00969475 Clinical Trial

The Effects of Fractional Carbon Dioxide (CO2) Laser Treatment Prior to Wound Closure

Scars Clinical Trial

Official title:
The Effects of Fractional CO2 Resurfacing Prior to Complex Wound Closure

Clinical Trial Details — Status: Unknown status

Administrative data
NCT number NCT00969475
Other study ID # MF-01
Secondary ID
Status Unknown status
Phase N/A
First received August 29, 2009
Last updated September 13, 2009
Start date October 2009
Est. completion date December 2009

Study information
Verified date September 2009
Source Moy-Fincher Medical Group
Contact Telia DeBoyes
Email tdeboyes@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if fractional carbon dioxide laser treatment of a fresh wound at the time of surgery, decreases scar formation. Scar revision is commonly done at 6-10 weeks following surgery. Therefore, it may be more beneficial, for both the patient and physician, to perform scar revision at the time of surgery.

Recruitment information / eligibility
Status Unknown status
Enrollment 10
Est. completion date December 2009
Est. primary completion date December 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Undergoing skin cancer surgery

- Will have a straight-line incision

- Fluent in English

- Must reside in the Los Angeles vicinity for the duration of the study

Exclusion Criteria:

- Non-English speakers

- Pregnant or cognitively impaired subjects

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Lumenis fractional carbon dioxide laser
intra-operative laser resurfacing at time of wound closure

Locations
Country Name City State
United States Moy-Fincher Medical Group Los Angeles California

Sponsors (1)
Lead Sponsor Collaborator
Moy-Fincher Medical Group

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Evidence of scar improvement as assessed by blinded-observer and patient ratings. At two and six weeks following the procedure
See also
  Status Clinical Trial Phase
Completed NCT04806594 - Clinical Investigation on the Safety and Clinical Performance of Papix Acne Scar. N/A
Completed NCT01700595 - Preexpanded Perforator Flaps in Children N/A
Recruiting NCT03782038 - Study to Evaluate the Efficacy of a Micro Coring Device for the Treatment of Scars of the Cytrellis Micro-Coring Device for the Treatment of Scars N/A
Recruiting NCT06202274 - Clinical Study to Evaluate the Safety and Efficacy of Candela Technology N/A
Not yet recruiting NCT02590042 - Safety of Adipose-Derived Stem Cell Stromal Vascular Fraction Phase 1
Completed NCT01932359 - Rapidly Absorbable Versus Non-absorbable Sutures for Mohs Surgery Repair on the Face: a Randomized Controlled Split-scar Study N/A
Completed NCT01091181 - The Effect of Hysterotomy Technique on the Rate of Large Defects in the Hysterotomy Scar N/A
Recruiting NCT06021275 - Microneedling With Regular Insulin Versus Microneedling Alone in Treatment of Atrophic Scars N/A
Recruiting NCT02195063 - Survey Study for Pain Management, Wound Care, Scar Care or UDT Phase 4
Terminated NCT00803140 - Cutaneous Scarring of Scalpel Versus Cautery N/A
Not yet recruiting NCT04593706 - Comparison of the Efficacy of Different Steroids in the Treatment of Abnormal Scars (Keloids, Hypertrophic Scars) N/A
Recruiting NCT05847530 - Pilot Evaluation of the Cynosure Potenza™ System for Treatment of Cosmetic Dermatologic Skin Conditions N/A
Withdrawn NCT01350739 - The Umbilical Access in Laparoscopic Surgery N/A
Completed NCT02145130 - Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects Phase 1
Completed NCT01358838 - Ablative 10600 nm Fractional Laser Therapy for the Treatment of Scars N/A
Completed NCT03880058 - Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance Phase 1/Phase 2
Recruiting NCT05528328 - Post-surgical Scars After the Use of CACIPLIQ20 Phase 3
Completed NCT00450775 - Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of Scars Phase 4
Completed NCT00580736 - Optical Clearing of the Skin in Conjunction With Laser Treatments Phase 1
Withdrawn NCT04269317 - Clinical Study to Evaluate the Safety and Effectiveness of the Treatment With Tixel C on Acne Scars N/A